This inventor holds 1 USPTO granted patent. Top assignee: Sygnis Bioscience Gmbh & Co Kg. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Bettina Klaussner
Introduction
Bettina Klaussner is a prominent inventor based in Auckland, New Zealand. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic approaches for neurological conditions. Her work is characterized by a focus on molecular biology and the potential for innovative treatments.
Latest Patents
Bettina Klaussner holds a patent for a nucleic acid molecule encoding a neuronal serine-threonine protein kinase. This invention relates to a gene and the coded protein involved in the development of sequelae of local ischaemia. The new protein is a serine-threonine protein kinase, which provides a novel therapeutic approach to the prophylaxis and therapy of apoplexy. This patent highlights her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Bettina is currently associated with Sygnis Bioscience GmbH & Co. KG, where she continues to push the boundaries of scientific research. Her career is marked by a dedication to understanding complex biological processes and translating that knowledge into practical applications.
Collaborations
Throughout her career, Bettina has collaborated with esteemed colleagues, including Armin Schneider and Achim Fischer. These partnerships have fostered an environment of innovation and have contributed to the success of her projects.
Conclusion
Bettina Klaussner's work exemplifies the spirit of innovation in the field of biotechnology. Her contributions, particularly in the area of therapeutic development, are paving the way for new treatments that could significantly impact patient care. Her dedication to research and collaboration underscores the importance of teamwork in scientific advancement.